Clinical trial / 2000
Oral curcumin administration was followed by complete recovery in four of five patients who completed treatment for inflammatory orbital pseudotumours.
Curcumin was orally administered at a dose of 375 mg three times daily for 6 to 22 months to 8 patients with idiopathic inflammatory orbital pseudotumours, followed up for 2 years at 3-month intervals. Five patients completed the study; four recovered completely, and in one patient, swelling regressed completely though some movement limitation persisted. No side effects were observed, and there was no recurrence.
- Study type
- Uncontrolled clinical study
- Who was studied
- 8 patients suffering from idiopathic inflammatory orbital pseudotumours
- What was measured
- Clinical recovery/efficacy, recurrence, and side effects
THE PAPER
Role of curcumin in idiopathic inflammatory orbital pseudotumours.
Lal B, Kapoor AK, Agrawal PK, Asthana OP, Srimal RC. Phytother Res, 2000.
PubMed 10960899 ↗DOI 10.1002/1099-1573(200009)14:6<443::aid-ptr619>3.0.co;2-v ↗
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.